2024 Q3 Form 10-Q Financial Statement
#000164033424001302 Filed on August 19, 2024
Income Statement
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
Revenue | $0.00 | $675.00 |
YoY Change | -100.0% | -71.14% |
Cost Of Revenue | $0.00 | $246.00 |
YoY Change | -100.0% | -71.02% |
Gross Profit | $0.00 | -$429.00 |
YoY Change | -100.0% | -128.79% |
Gross Profit Margin | -63.56% | |
Selling, General & Admin | $54.06K | |
YoY Change | -4.76% | |
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | $0.00 | |
YoY Change | -100.0% | |
% of Gross Profit | ||
Operating Expenses | $121.9K | $93.41K |
YoY Change | 25.89% | 62.62% |
Operating Profit | -$121.9K | -$92.98K |
YoY Change | 32.24% | 66.18% |
Interest Expense | $9.697K | $17.97K |
YoY Change | -52.98% | -65.61% |
% of Operating Profit | ||
Other Income/Expense, Net | $84.29K | -$90.04K |
YoY Change | 6.49% | 2.35% |
Pretax Income | -$183.0K | |
YoY Change | 27.17% | |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$37.65K | -$183.0K |
YoY Change | 188.26% | 27.17% |
Net Earnings / Revenue | -27113.63% | |
Basic Earnings Per Share | $0.00 | |
Diluted Earnings Per Share | $0.00 | |
COMMON SHARES | ||
Basic Shares Outstanding | 1.232B shares | 1.175B shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $240.00 | |
YoY Change | -99.4% | |
Cash & Equivalents | $43.89K | $235.00 |
Short-Term Investments | ||
Other Short-Term Assets | $2.500K | |
YoY Change | ||
Inventory | $0.00 | $6.000K |
Prepaid Expenses | $0.00 | $0.00 |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $46.39K | $8.735K |
YoY Change | -71.48% | -81.27% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% |
TOTAL ASSETS | ||
Total Short-Term Assets | $46.39K | $8.735K |
Total Long-Term Assets | $0.00 | $0.00 |
Total Assets | $46.39K | $8.735K |
YoY Change | -85.91% | -81.9% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $3.280K | |
YoY Change | 135.29% | |
Accrued Expenses | $162.2K | $152.8K |
YoY Change | 28.41% | 10671.46% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $349.8K | |
YoY Change | -7.23% | |
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $1.852M | $1.930M |
YoY Change | 25.53% | 11.79% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | |
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $0.00 | |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $1.852M | $1.930M |
Total Long-Term Liabilities | $0.00 | |
Total Liabilities | $1.852M | $1.930M |
YoY Change | 25.53% | 11.79% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$8.792M | -$8.754M |
YoY Change | 9.95% | 9.66% |
Common Stock | $123.2K | $123.2K |
YoY Change | 58.63% | 113.67% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$1.805M | -$1.922M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $46.39K | $8.735K |
YoY Change | -85.91% | -81.9% |
Cashflow Statement
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$37.65K | -$183.0K |
YoY Change | 188.26% | 27.17% |
Depreciation, Depletion And Amortization | $0.00 | |
YoY Change | -100.0% | |
Cash From Operating Activities | -$51.46K | |
YoY Change | -9.51% | |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 32.10K | |
YoY Change | -64.74% | |
NET CHANGE | ||
Cash From Operating Activities | -51.46K | |
Cash From Investing Activities | ||
Cash From Financing Activities | 32.10K | |
Net Change In Cash | -19.36K | |
YoY Change | -156.66% | |
FREE CASH FLOW | ||
Cash From Operating Activities | -$51.46K | |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q2 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
311000 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
2.35 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0131 | pure | |
bdpt |
Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm
|
P2Y | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001575142 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1250000000 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1231728974 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
895760225 | shares |
CY2023Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
10000 | shares |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-06-30 | ||
dei |
Entity File Number
EntityFileNumber
|
000-54949 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
BioAdaptives Inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
46-2592228 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
2620 Regatta Drive | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 102 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Las Vegas | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NV | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
89128 | ||
dei |
City Area Code
CityAreaCode
|
702 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
659-8829 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
false | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2024Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
1231728974 | shares |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
235 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
60776 | usd |
CY2024Q2 | us-gaap |
Inventory Net
InventoryNet
|
6000 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
15281 | usd |
CY2024Q2 | us-gaap |
Security Deposit
SecurityDeposit
|
2500 | usd |
CY2023Q4 | us-gaap |
Security Deposit
SecurityDeposit
|
2500 | usd |
CY2024Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
0 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
10000 | usd |
CY2024Q2 | us-gaap |
Assets Current
AssetsCurrent
|
8735 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
88557 | usd |
CY2024Q2 | us-gaap |
Indefinite Lived License Agreements
IndefiniteLivedLicenseAgreements
|
0 | usd |
CY2023Q4 | us-gaap |
Indefinite Lived License Agreements
IndefiniteLivedLicenseAgreements
|
15441 | usd |
CY2024Q2 | us-gaap |
Assets
Assets
|
8735 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
103998 | usd |
CY2024Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
458205 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
443579 | usd |
CY2024Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
1122486 | usd |
CY2023Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
977872 | usd |
CY2024Q2 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
311000 | usd |
CY2023Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
321658 | usd |
CY2024Q2 | us-gaap |
Notes Payable
NotesPayable
|
32096 | usd |
CY2023Q4 | us-gaap |
Notes Payable
NotesPayable
|
0 | usd |
CY2024Q2 | bdpt |
Notes Payable Related Parties Classified As Current
NotesPayableRelatedPartiesClassifiedAsCurrent
|
6660 | usd |
CY2023Q4 | bdpt |
Notes Payable Related Parties Classified As Current
NotesPayableRelatedPartiesClassifiedAsCurrent
|
7520 | usd |
CY2024Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1930447 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1750629 | usd |
CY2024Q2 | us-gaap |
Liabilities
Liabilities
|
1930447 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
1750629 | usd |
CY2024Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
123173 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
89576 | usd |
CY2024Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
6708259 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
6527428 | usd |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-8753869 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-8264145 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1921712 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1646631 | usd |
CY2024Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
8735 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
103998 | usd |
CY2024Q2 | us-gaap |
Revenues
Revenues
|
675 | usd |
CY2023Q2 | us-gaap |
Revenues
Revenues
|
2339 | usd |
us-gaap |
Revenues
Revenues
|
12669 | usd | |
us-gaap |
Revenues
Revenues
|
5715 | usd | |
CY2024Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
246 | usd |
CY2023Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
849 | usd |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
8639 | usd | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
2245 | usd | |
CY2024Q2 | us-gaap |
Gross Profit
GrossProfit
|
-429 | usd |
CY2023Q2 | us-gaap |
Gross Profit
GrossProfit
|
1490 | usd |
us-gaap |
Gross Profit
GrossProfit
|
-4030 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
3470 | usd | |
CY2024Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4617 | usd |
CY2023Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
14516 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
36289 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
26552 | usd | |
CY2024Q2 | us-gaap |
Professional Fees
ProfessionalFees
|
49438 | usd |
CY2023Q2 | us-gaap |
Professional Fees
ProfessionalFees
|
42246 | usd |
us-gaap |
Professional Fees
ProfessionalFees
|
69290 | usd | |
us-gaap |
Professional Fees
ProfessionalFees
|
50496 | usd | |
CY2024Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
18000 | usd |
CY2023Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
677 | usd |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
19941 | usd | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1346 | usd | |
CY2024Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
93407 | usd |
CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
57439 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
146840 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
78394 | usd | |
CY2024Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-92978 | usd |
CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-55949 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-142810 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-74924 | usd | |
CY2024Q2 | us-gaap |
Other Income
OtherIncome
|
4950 | usd |
CY2023Q2 | us-gaap |
Other Income
OtherIncome
|
0 | usd |
us-gaap |
Other Income
OtherIncome
|
4950 | usd | |
us-gaap |
Other Income
OtherIncome
|
0 | usd | |
CY2024Q2 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
0 | usd |
CY2023Q2 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
-10 | usd |
us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
0 | usd | |
us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
-20 | usd | |
CY2024Q2 | us-gaap |
Interest Expense
InterestExpense
|
17969 | usd |
CY2023Q2 | us-gaap |
Interest Expense
InterestExpense
|
52253 | usd |
us-gaap |
Interest Expense
InterestExpense
|
72584 | usd | |
us-gaap |
Interest Expense
InterestExpense
|
103316 | usd | |
CY2024Q2 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-77020 | usd |
CY2023Q2 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-35705 | usd |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-279280 | usd | |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-252844 | usd | |
CY2024Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-90039 | usd |
CY2023Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-87968 | usd |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-346914 | usd | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-356180 | usd | |
CY2024Q2 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
-183017 | usd |
CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
-143917 | usd |
us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
-489724 | usd | |
us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
-431104 | usd | |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-183017 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-143917 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-489724 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-431104 | usd | |
CY2024Q2 | bdpt |
Basic And Diluted Earning Per Share
BasicAndDilutedEarningPerShare
|
-0.00 | |
CY2023Q2 | bdpt |
Basic And Diluted Earning Per Share
BasicAndDilutedEarningPerShare
|
-0.00 | |
bdpt |
Basic And Diluted Earning Per Share
BasicAndDilutedEarningPerShare
|
-0.00 | ||
bdpt |
Basic And Diluted Earning Per Share
BasicAndDilutedEarningPerShare
|
-0.00 | ||
CY2024Q2 | bdpt |
Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
|
895760225 | shares |
CY2023Q2 | bdpt |
Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
|
441742955 | shares |
bdpt |
Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
|
1105010656 | shares | |
bdpt |
Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
|
355268125 | shares | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1646631 | usd |
CY2024Q1 | bdpt |
Series A Preferred Stock Issued For License Fee Amount
SeriesAPreferredStockIssuedForLicenseFeeAmount
|
1500 | usd |
CY2024Q1 | bdpt |
Series B Preferred Stock Issued For License Fee Amount
SeriesBPreferredStockIssuedForLicenseFeeAmount
|
3000 | usd |
CY2024Q1 | bdpt |
Series B Preferred Stock Issued For Settlement Of Debt Amount
SeriesBPreferredStockIssuedForSettlementOfDebtAmount
|
1500 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
149455 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-306707 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1797883 | usd |
CY2024Q2 | bdpt |
Series C Preferred Stock Issued For Purchase Of Inventory Amount
SeriesCPreferredStockIssuedForPurchaseOfInventoryAmount
|
6000 | usd |
CY2024Q2 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
53188 | usd |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-183017 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1921712 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1451501 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
108036 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-287187 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1630652 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
96057 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-143917 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1678512 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
489724 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
431104 | usd | |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-279280 | usd | |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-252844 | usd | |
us-gaap |
Impairment Of Real Estate
ImpairmentOfRealEstate
|
18000 | usd | |
us-gaap |
Impairment Of Real Estate
ImpairmentOfRealEstate
|
0 | usd | |
us-gaap |
Impairment Of Investments
ImpairmentOfInvestments
|
21350 | usd | |
us-gaap |
Impairment Of Investments
ImpairmentOfInvestments
|
0 | usd | |
bdpt |
Amortization Of Other Intangible Assets
AmortizationOfOtherIntangibleAssets
|
1941 | usd | |
bdpt |
Amortization Of Other Intangible Assets
AmortizationOfOtherIntangibleAssets
|
1346 | usd | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
52592 | usd | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
82385 | usd | |
bdpt |
Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investment
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment
|
0 | usd | |
bdpt |
Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investment
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestment
|
-21 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
6069 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-2390 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-10000 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
0 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
19993 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
15791 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-92637 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-76328 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
0 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
51044 | usd | |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
32096 | usd | |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
0 | usd | |
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | usd | |
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
40000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
32096 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
91044 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-60541 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
14716 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
60776 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
25405 | usd |
CY2024Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
235 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
40121 | usd |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd | |
bdpt |
Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
|
0 | usd | |
bdpt |
Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
|
110000 | usd | |
us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
202643 | usd | |
us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
204093 | usd | |
bdpt |
Series A Preferred Stock Issued For License Fee
SeriesAPreferredStockIssuedForLicenseFee
|
1500 | usd | |
bdpt |
Series A Preferred Stock Issued For License Fee
SeriesAPreferredStockIssuedForLicenseFee
|
0 | usd | |
us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
3000 | usd | |
us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
0 | usd | |
bdpt |
Issuance Series C Preferred Stock For Purchase Of Inventory
IssuanceSeriesCPreferredStockForPurchaseOfInventory
|
6000 | usd | |
bdpt |
Issuance Series C Preferred Stock For Purchase Of Inventory
IssuanceSeriesCPreferredStockForPurchaseOfInventory
|
0 | usd | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of consolidated financial statements in conformity with US GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. These estimates and judgments are based on historical information, information that is currently available to the Company, and on various other assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p> |